Alnylam to webcast presentation at canaccord genuity 43rd annual growth conference

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will present a company overview at the canaccord genuity 43rd annual growth conference on thursday, august 10, 2023 at 10:30 am et at the intercontinental hotel in boston. a live audio webcast of the presentation will be available on the investors section of the company's website at www.alnylam.com/events. a replay will be available on the alnyl.
ALNY Ratings Summary
ALNY Quant Ranking